ClinicalTrials.gov
public full text
Public Domain
Fase I Clinical Trial on NK Cells for COVID-19
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Viral Specific T-cells for Treatment of COVID-19#993065
- A Study of Immune Responses to the Virus That Causes COVID-19#802134
- Commentary : mesenchymal stem cells : a new piece in the puzzle of COVID-19 treatment#1040771
- COVID-19 VACCINE SAFETY AND EFFECTIVENESS#903399
- Anti-SARS Cov-2 T Cell Infusions for COVID 19#968207
Record · ID 390958
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive